PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF LYMPHOCYTES IN MYASTHENIA-GRAVIS

被引:0
作者
LEVINSON, AI
LISAK, RP
ZWEIMAN, B
KORNSTEIN, M
机构
[1] UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104
来源
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1985年 / 8卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:209 / 233
页数:25
相关论文
共 135 条
[1]   LYMPHOCYTE SUB-POPULATIONS IN THYMUS AND BLOOD FROM PATIENTS WITH MYASTHENIA-GRAVIS [J].
AARLI, JA ;
HEIMANN, P ;
MATRE, R ;
THUNOLD, S ;
TONDER, O .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1979, 42 (01) :29-34
[2]   THYMUS IN MYASTHENIA-GRAVIS - EVIDENCE FOR ALTERED CELL-POPULATIONS [J].
ABDOU, NI ;
LISAK, RP ;
ZWEIMAN, B ;
ABRAHAMSOHN, I ;
PENN, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (24) :1271-1275
[3]   NETWORK THEORY IN AUTOIMMUNITY - INVITRO SUPPRESSION OF SERUM ANTI-DNA ANTIBODY-BINDING TO DNA BY ANTI-IDIOTYPIC ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABDOU, NI ;
WALL, H ;
LINDSLEY, HB ;
HALSEY, JF ;
SUZUKI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1297-1304
[4]  
ABRAMSKY O, 1975, CLIN EXP IMMUNOL, V19, P11
[5]   IMMUNOLOGIC STUDIES OF THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS WITH MYASTHENIA GRAVIS [J].
ADNER, MM ;
ISE, C ;
SCHWAB, R ;
SHERMAN, JD ;
DAMESHEK, W .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1966, 135 (A1) :536-&
[6]   ACCELERATED DEGRADATION OF ACETYLCHOLINE-RECEPTOR FROM CULTURED RAT MYOTUBES WITH MYASTHENIA-GRAVIS SERA AND GLOBULINS [J].
APPEL, SH ;
ANWYL, R ;
MCADAMS, MW ;
ELIAS, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (05) :2130-2134
[7]   THYMIC LYMPHOCYTE FUNCTION IN MYASTHENIA-GRAVIS [J].
ARMSTRONG, RM ;
NOWAK, RM ;
FALK, RE .
NEUROLOGY, 1973, 23 (10) :1078-1083
[8]  
BACH JF, 1972, LANCET, V2, P1056
[9]   ABSENCE OF CELLULAR-HYPERSENSITIVITY TO MUSCLE AND THYMIC ANTIGENS IN MYASTHENIA-GRAVIS [J].
BEHAN, WMH ;
BEHAN, PO ;
SIMPSON, JA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1975, 38 (11) :1039-1047
[10]  
BERRIH S, 1981, CLIN EXP IMMUNOL, V45, P1